Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | GABRP | O00591 | 2/20 | 0.47 |
| ▸ | GABRD | O14764 | 2/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.47 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.47 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.47 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.47 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.47 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.47 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.47 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.47 |
| ▸ | GABRE | P78334 | 2/20 | 0.47 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.47 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.47 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29361061 | 1.00 | KIF11 (1.00) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| SCHEMBL29931435 | 0.98 | KIF11 (0.96) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| Water SCHEMBL28120324 | 0.96 | KIF11 (0.93) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| SCHEMBL27954019 | 0.95 | KIF11 (0.90) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| Boric Acid SCHEMBL28474551 | 0.93 | KIF11 (0.87) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| Phenazine SCHEMBL28676092 | 0.90 | KIF11 (0.81) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| Dibenzothiophene SCHEMBL28150944 | 0.90 | KIF11 (0.81) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| SCHEMBL28914343 | 0.89 | KIF11 (0.79) | KIF11ALDH1A1HSD17B10MAPTGABRP | |
| Dibenzofuran SCHEMBL28138157 | 0.89 | KIF11 (0.79) | KIF11ALDH1A1HSD17B10GPR3MAPT | |
| Benzophenone SCHEMBL28302559 | 0.86 | KIF11 (0.74) | KIF11ALDH1A1MAPTJAK2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 750 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504815-A | Boron-nitrogen compound, preparation method, light-emitting layer, organic electroluminescent device and display device | 季华实验室 | 2025-02-25 | — | — | CN | claimed |
| CN-118388449-A | Photocatalyst with space charge transfer property and preparation method and application thereof | 广东工业大学 | 2024-07-26 | — | — | CN | claimed |
| CN-117264001-A | Excited state intramolecular proton transfer induced delayed fluorescence probe molecule, preparation and application thereof | 中国医学科学院药物研究所 | 2023-12-22 | — | — | CN | claimed |
| CN-116444502-A | Organic light-emitting compound containing dibenzosuberone, preparation method and application | 华南理工大学 | 2023-07-18 | — | — | CN | claimed |
| CN-114671854-B | High-solubility electron acceptor material and preparation method and application thereof | 电子科技大学 | 2023-04-28 | — | — | CN | claimed |
| CN-113248487-B | Carbazole/oxadiazole-based thermal activation delayed fluorescence material and preparation method and application thereof | 南京工业大学 | 2023-04-07 | — | — | CN | claimed |
| US-11401465-B2 | Thermally activated delayed fluorescent and synthesizing method thereof | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2022-08-02 | — | — | US | claimed |
| CN-111646942-B | Heat activation delayed fluorescence probe molecule, preparation thereof and application thereof in cell imaging | 中国医学科学院药物研究所 | 2022-07-19 | — | — | CN | claimed |
| CN-114671854-A | High-solubility electron acceptor material and preparation method and application thereof | 电子科技大学 | 2022-06-28 | — | — | CN | claimed |
| CN-113801102-A | Phenazinyl-based compound and preparation method and application thereof | 上海交通大学 | 2021-12-17 | — | — | CN | claimed |
| CN-106883268-A | Based on phosphine oxygen, the triazines exciplex material of carbazole and its preparation method and application | 黑龙江大学 | 2017-06-23 | — | — | CN | claimed |
| CN-106831861-A | A kind of fluorenes and carbazole analog derivative and phosphorescent organic electroluminescent device | 武汉华星光电技术有限公司 | 2017-06-13 | — | — | CN | claimed |
| CN-103641856-B | Multifunctional modified tert-butyl carbazole phosphine oxide main material and synthesis method and application thereof | 黑龙江大学 | 2017-01-25 | — | — | CN | claimed |
| CN-104212439-B | A kind of photoelectric functional material containing N-P=S resonant structure, preparation method and application | 南京邮电大学 | 2016-08-17 | — | — | CN | claimed |
| CN-105399662-A | Pyridyl bifluorene derivative blue light main body material preparation method | UNIV NANJING POSTS & TELECOMMUNICATIONS | 2016-03-16 | — | — | CN | claimed |
| US-20040043999-A1 | Phthalazine derivatives as phosphodiesterase 4-inhibitors | ZAMBON GROUP S.P.A | 2004-03-04 | — | — | US | claimed |
| EP-1042300-B1 | PHTHALAZINE DERIVATIVES USEFUL AS PHOSPHODIESTERASE 4 INHIBITORS | ZAMBON SPA (IT) | 2004-02-11 | — | — | EP | claimed |
| US-6589951-B1 | N right-arrowO derivatives and pharmaceutically acceptable salt thereof are PDE 4 and TNF pharmaceutically acceptable salt thereof are PDE 4 and TNF alpha inhibitors. | ZAMBON GROUP S.P.A. (IT) | 2003-07-08 | — | — | US | claimed |
| EP-1042300-A1 | PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS | ZAMBON GROUP S.p.A. (IT) | 2000-10-11 | — | — | EP | claimed |
| WO-1999032456-A1 | PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS | ZAMBON GROUP S.P.A. (IT) | 1999-07-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040043999-A1 | Phthalazine derivatives as phosphodiesterase 4-inhibitors | PDE5A, PDE3B, PDE3A | KIF11 2617/4885ALDH1A1 780/4885HSD17B10 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.